High-dose dexamethasone in the treatment of HELLP syndrome

International Journal of Gynecology and Obstetrics

Volumn 93, Issue 2, 2006, Pages 140-141

  Mould, S ^a   Paruk, F ^a   Moodley, J ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

HELLP syndrome; High dose dexamethasone

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETAMETHASONE; DEXAMETHASONE; MAGNESIUM SULFATE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HELLP SYNDROME; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE COUNT; UNSPECIFIED SIDE EFFECT;

EID: 33646071556     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2006.01.017     Document Type: Article

References (3)

1. Sibai B.M., Taslimi M.M., El-Nazer A., Amon E., Mabie B.C., and Ryan G.M. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe pre-eclampsia/eclampsia. Am J Obstet Gynecol 155 (1986) 501-509
2. Martin J.N., Perry K.G., Blake P.G., May W.A., Moore A., and Robinette L. Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP syndrome. Am J Obstet Gynecol 177 (1997) 1011-1017
3. Fonseca J.E., Mendez F., and Cantano C. Dexamethasone treatment does not improve the outcome of women with the HELLP syndrome: a double-blind placebo-controlled randomised clinical trial. Am J Obstet Gynecol 193 (2005) 1591-1598